Luxembourg
Eurofins, with its slogan "With ca. 62,000 staff across 62 countries, Eurofins provides testing, inspection, and certification services," is a prominent player in the Biotechnology industry. Headquartered in Luxembourg, the company was founded in 1987 and has since expanded from one laboratory in Nantes, France, to over 950 laboratories across 59 countries.
The company conducts more than 450 million tests annually, offering a vast portfolio of over 200,000 analytical methods. These services assess the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products. Additionally, Eurofins provides specialized clinical diagnostic testing services, marking it as a leader in the field.
Having gone public in 1997, the company is recognized for its rapid growth, consistently ranking among the fastest-growing listed European companies. Its last noted investment was a €500.00M Post-IPO Debt infusion on 01 June 2025, underscoring continued confidence in its scalable and innovative growth trajectory.
